CSBR:NASDAQ
Champions Oncology Inc
USD 4,70
arrow_upward
+0,43%(+0,020) 1D
17 Nov., 10:03:12 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
USD 4,70
High
USD 4,70
Low
USD 4,70
Mkt. cap
65,42 m
Avg. vol.
7,80 k
Volume
1,06 k
52-wk high
USD 8,31
52-wk low
USD 4,52
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
Open
USD 4,70
High
USD 4,70
Low
USD 4,70
Mkt. cap
65,42 m
Avg. vol.
7,80 k
Volume
1,06 k
52-wk high
USD 8,31
52-wk low
USD 4,52
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
News stories
From web sources and news partners
TradingView
·
1 uur gelede
Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Trade Mixed Ahead of Nvidia’s Q3 Earnings— CBRS, AMZN, RCAT in Focus (UPDATED)
The Motley Fool
·
1 uur gelede
Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500
Coinpaper
·
32 minute gelede
Stock Market Today: S&P 500 Struggles Ahead of Nvidia Earnings After $2 Trillion Stock Rout
The Defiant
·
14 uur gelede
Ondo Launches S&P 500 Portfolio Token With Loss Buffers
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, Verenigde State van Amerika
SectorHealth Care
Industry-
Websitechampionsoncology.com